Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: A prospective cohort study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Iimori, Soichiro ^a   Noda, Yumi ^a   Okado, Tomokazu ^a   Naito, Shotaro ^a   Toda, Takayuki ^b   Chida, Yoshiko ^c   Kuwahara, Michio ^d   Ando, Ryoichi ^e   Nishio, Yasuhide ^f   Maeda, Yoshitaka ^g   Tanaka, Hiroyuki ^h   Tamura, Teiichi ^h   Kimoto, Shigeaki ⁱ   Kanda, Eiichiro ^j   Inoshita, Seiji ^k   Yoshikawa, Momono ^l   Okutsu, Rie ^m   Tajima, Masato ⁿ   Kusaura, Takashi ^o   Kobayashi, Katsuki ^p   Rai, Tatemitsu ^a   Uchida, Shinichi ^a   Sasaki, Sei ^a   more..

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^c Nakano General Hospital   (Japan)

^d Shuuwa General Hospital   (Japan)

^e MUSASHINO RED CROSS HOSPITAL   (Japan)

^f TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^g JA Toride Medical Center   (Japan)

^h YOKOSUKA KYOSAI HOSPITAL   (Japan)

ⁱ Ome Municipal General Hospital   (Japan)

^j TOKYO KYOSAI HOSPITAL   (Japan)

^k TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^l Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^m Toshima Tokyo Metropolitan Hospital   (Japan)

ⁿ TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^o Hiratsuka Kyosai Hospital   (Japan)

^p SAKURA NATIONAL HOSPITAL   (Japan)

more..

Author keywords

Cardiovascular disease; Chronic kidney disease; Cohort study; Epidemiology; Nephrologist

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; PROTEINURIA; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84880183676     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-152     Document Type: Article

References (26)

1. Prevalence of chronic kidney disease in the Japanese general population. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, et al. Clin Exp Nephrol 2009 13 6 621 630 10.1007/s10157-009-0199-x 19513802
2. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 17 2038 2047 10.1001/jama.298.17.2038 17986697
3. An Overview of Regular Dialysis Treatment in Japan http://docs.jsdt.or. jp/overview/index.html
4. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 13 1296 1305 10.1056/NEJMoa041031 15385656
5. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ, J Am Soc Nephrol 2004 15 5 1307 1315 10.1097/01.ASN.0000123691.46138. E2 15100371
6. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, et al. Arch Intern Med 2007 167 11 1122 1129 10.1001/archinte.167. 11.1122 17563019
7. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH, Arch Intern Med 2004 164 6 659 663 10.1001/archinte.164.6.659 15037495
8. Excerpts from the US Renal Data System 2009 Annual Data Report. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, et al. Am J Kidney Dis 2010 55 1 Suppl 1 1 S420 A426-427 20420966
9. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D, De Jong PE, J Intern Med 2001 249 6 519 526 10.1046/j.1365-2796.2001.00833.x 11422658
10. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, et al. J Am Soc Nephrol 2009 20 8 1813 1821 10.1681/ASN.2008121270 19443635
11. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Drury PL, Ting R, Zannino D, Ehnholm C, Flack J, Whiting M, Fassett R, Ansquer JC, Dixon P, Davis TM, et al. Diabetologia 2011 54 1 32 43 10.1007/s00125-010-1854-1 20668832
12. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G, Kidney Int 2005 67 6 2089 2100 10.1111/j.1523-1755.2005. 00365.x 15882252
13. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD, Nephron Clin Pract 2008 109 3 109 c118 10.1159/000145453 18663322
14. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, Kitamura H, Imai E, Rakugi H, Isaka Y, et al. Clin J Am Soc Nephrol 2010 5 9 1558 1565 10.2215/CJN.08061109 20558563
15. Revised equations for estimated GFR from serum creatinine in Japan. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Am J Kidney Dis 2009 53 6 982 992 10.1053/j.ajkd.2008.12. 034 19339088
16. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol 2009 13 6 537 566 19960305
17. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi 2012 54 8 1034 1191 23387281
18. Global Database on Body Mass Index http://apps.who.int/bmi/index.jsp ]
19. FAO Statistical Yearbook 2012 http://www.fao.org/docrep/015/i2490e/ i2490e00.htm ]
20. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, et al. Clin J Am Soc Nephrol 2009 4 8 1302 1311 10.2215/CJN.00070109 19541818
21. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS, Joffe M, Nessel LA, Ojo A, et al. Am J Nephrol 2011 33 6 477 484 10.1159/000327618 21525746
22. Factors associated with kidney disease progression and mortality in a referred CKD population. Hoefield RA, Kalra PA, Baker P, Lane B, New JP, O'Donoghue DJ, Foley RN, Middleton RJ, Am J Kidney Dis 2010 56 6 1072 1081 10.1053/j.ajkd.2010.06.010 20692750
23. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. Martinez-Castelao A, Gorriz JL, Portoles JM, De Alvaro F, Cases A, Luno J, Navarro-Gonzalez JF, Montes R, De la Cruz-Troca JJ, Natarajan A, et al. BMC Nephrol 2011 12 53 10.1186/1471-2369-12-53 21970625
24. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies. Miura K, Nakagawa H, Ohashi Y, Harada A, Taguri M, Kushiro T, Takahashi A, Nishinaga M, Soejima H, Ueshima H, Circulation 2009 119 14 1892 1898 10.1161/CIRCULATIONAHA.108.823112 19332464
25. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003 41 4 Suppl 3 -IV S1-91 12671933
26. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Astor BC, Muntner P, Levin A, Eustace JA, Coresh J, Arch Intern Med 2002 162 12 1401 1408 10.1001/archinte.162.12. 1401 12076240